Kristina Burow insider trades

Open-market stock purchases and sales by Kristina Burow, Director at Scholar Rock Holding Corp, from SEC Form 4 filings since May 14, 2013.

Track record: 8% of 25 scored buys are up 5% or more since purchase, averaging -53%.

Recent trades

DateStockTradeValue
Jun 4, 2026SRRK Scholar Rock Holding CorpBought (not open market)—
Jun 4, 2026SRRK Scholar Rock Holding CorpBought (not open market)—
May 27, 2026NMRA Neumora Therapeutics, IncBought (not open market)—
Apr 23, 2026SRRK Scholar Rock Holding CorpBought (not open market)—
Apr 23, 2026SRRK Scholar Rock Holding CorpBought (not open market)—
Apr 23, 2026SRRK Scholar Rock Holding CorpBought (not open market)—
Apr 23, 2026SRRK Scholar Rock Holding CorpBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)$472K
Nov 13, 2025MTSR Metsera, IncSold (not open market)$1.2M
Oct 27, 2025NMRA Neumora Therapeutics, IncBought$5M

Companies traded

  • SRRK Scholar Rock Holding Corp: 2 sales, last Jun 4, 2026
  • NMRA Neumora Therapeutics, Inc: 20 buys, last May 27, 2026
  • MTSR Metsera, Inc: 2 buys, last Nov 13, 2025
  • BOLD Boundless Bio, Inc: 2 buys, last Jun 23, 2025
  • GOSS Gossamer Bio, Inc: other filings, last Jun 8, 2023
  • BEAM Beam Therapeutics Inc: other filings, last Jun 6, 2023
  • UBX Unity Biotechnology, Inc: other filings, last Jun 24, 2021
  • MTCR Metacrine, Inc: 2 buys, last May 24, 2021
  • VIR Vir Biotechnology, Inc: 1 buy, last May 21, 2020
  • SNNA Sienna Biopharmaceuticals, Inc: 2 buys, last May 30, 2019
  • RCPT Receptos, Inc: 1 buy, 12 sales, last Aug 27, 2015

Get free alerts when Kristina Burow files a new trade →